MANNKIND CORP Nontrade Receivables, Noncurrent
MANNKIND CORP (MNKD) had Nontrade Receivables, Noncurrent of $311.00 thousand as of 2014-12-31, per its 10-K filed 2016-03-15.
Discontinued › Notes
us-gaap:NontradeReceivablesNoncurrent · last filed 2016-03-15
- 2014-12-31: Nontrade Receivables, Noncurrent $311.00K.
- 2014-09-30: Nontrade Receivables, Noncurrent $260.00K.
- 2014-06-30: Nontrade Receivables, Noncurrent $463.00K.
- 2014-03-31: Nontrade Receivables, Noncurrent $380.00K.
| Period end | Nontrade Receivables, Noncurrent |
|---|---|
| 2014-12-31 | $311.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $260.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $463.00K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $380.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $298.00K 10-K · filed 2015-03-02 |
| 2013-09-30 | $223.00K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $470.00K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $391.00K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $313.00K 10-K · filed 2014-03-03 |
| 2012-09-30 | $293.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $658.00K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $565.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $473.00K 10-K · filed 2013-03-18 |
| 2011-09-30 | $386.00K 10-Q · filed 2011-11-04 |
| 2011-06-30 | $885.00K 10-Q · filed 2011-08-04 |
| 2010-12-31 | $629.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |